Repository logo
 
Publication

Monitoring Adherence to Asthma Inhalers Using the InspirerMundi App: Analysis of Real-World, Medium-Term Feasibility Studies

2021Journal article Open access
Simple item page
dc.contributor.authorJácome, C
dc.contributor.authorAlmeida, R
dc.contributor.authorPereira, AM
dc.contributor.authorAmaral, R
dc.contributor.authorVieira-Marques, P
dc.contributor.authorMendes, S
dc.contributor.authorAlves-Correia, M
dc.contributor.authorFerreira, JA
dc.contributor.authorLopes, I
dc.contributor.authorGomes, J
dc.contributor.authorAraújo, L
dc.contributor.authorCouto, M
dc.contributor.authorChaves Loureiro, C
dc.contributor.authorMaia Santos, L
dc.contributor.authorArrobas, A
dc.contributor.authorValério, M
dc.contributor.authorTodo Bom, A
dc.contributor.authorAzevedo, J
dc.contributor.authorTeixeira, MF
dc.contributor.authorFerreira-Magalhães, M
dc.contributor.authorLeiria Pinto, P
dc.contributor.authorPinto, N
dc.contributor.authorCastro Neves, A
dc.contributor.authorMorête, A
dc.contributor.authorTodo Bom, F
dc.contributor.authorCosta, A
dc.contributor.authorSilva, D
dc.contributor.authorVasconcelos, MJ
dc.contributor.authorFalcão, H
dc.contributor.authorMarques, ML
dc.contributor.authorMendes, A
dc.contributor.authorCardoso, J
dc.contributor.authorCidrais Rodrigues, JC
dc.contributor.authorOliveira, G
dc.contributor.authorCarvalho, J
dc.contributor.authorLozoya, C
dc.contributor.authorSantos, N
dc.contributor.authorMenezes, F
dc.contributor.authorGomes, R
dc.contributor.authorCâmara, R
dc.contributor.authorRodrigues Alves, R
dc.contributor.authorMoreira, AS
dc.contributor.authorAbreu, C
dc.contributor.authorSilva, R
dc.contributor.authorBordalo, D
dc.contributor.authorAlves, C
dc.contributor.authorLopes, C
dc.contributor.authorTaborda-Barata, L
dc.contributor.authorFernandes, RM
dc.contributor.authorFerreira, R
dc.contributor.authorChaves-Loureiro, C
dc.contributor.authorCálix, MJ
dc.contributor.authorAlves, A
dc.contributor.authorAlmeida Fonseca, J
dc.date.accessioned2022-03-14T16:19:29Z
dc.date.available2022-03-14T16:19:29Z
dc.date.issued2021
dc.description.abstractBackground: Poor medication adherence is a major challenge in asthma and objective assessment of inhaler adherence is needed. InspirerMundi app aims to monitor inhaler adherence while turning it into a positive experience through gamification and social support. Objective: We assessed the medium-term feasibility of the InspirerMundi app to monitor inhaler adherence in real-world patients with persistent asthma (treated with daily inhaled medication). In addition, we attempted to identify the characteristics of the patients related to higher app use. Methods: Two real-world multicenter observational studies, with one initial face-to-face visit and a 4-month telephone interview, were conducted in 29 secondary care centers from Portugal. During an initial face-to-face visit, patients were invited to use the app daily to register their asthma medication intakes. A scheduled intake was considered taken when patients took a photo of the medication (inhaler, blister, or others) using the image-based medication detection tool. Medication adherence was calculated as the number of doses taken as a percentage of the number scheduled. Interacting with the app ≥30 days was used as the cut-off for higher app use. Results: A total of 114 patients {median 20 [percentile 25 to percentile 75 (P25-P75) 16-36] years, 62% adults} were invited, 107 (94%) installed the app and 83 (73%) completed the 4-month interview. Patients interacted with the app for a median of 18 [3-45] days, translated on a median use rate of 15 [3-38]%. Median inhaler adherence assessed through the app was 34 [4-73]% when considering all scheduled inhalations for the study period. Inhaler adherence assessed was not significantly correlated with self-reported estimates. Median adherence for oral and other medication was 41 [6-83]% and 43 [3-73]%, respectively. Patients with higher app use were slightly older (p = 0.012), more frequently taking medication for other health conditions (p = 0.040), and more frequently prescribed long-acting muscarinic antagonists (LAMA, p = 0.024). After 4 months, Control of Allergic Rhinitis and Asthma Test (CARAT) scores improved (p < 0.001), but no differences between patients interacting with the app for 30 days or less were seen. Conclusions: The InspirerMundi app was feasible to monitor inhaler adherence in patients with persistent asthma. The persistent use of this mHealth technology varies widely. A better understanding of characteristics related to higher app use is still needed before effectiveness studies are undertaken.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationFront Med Technol . 2021 Jul 15;3:649506pt_PT
dc.identifier.doi10.3389/fmedt.2021.649506pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4003
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherFrontiers Media SApt_PT
dc.subjectmHealthpt_PT
dc.subjectMedication adherencept_PT
dc.subjectPatient participationpt_PT
dc.subjectSelf-managementpt_PT
dc.subjectSmartphonept_PT
dc.subjectTechnology assessmentpt_PT
dc.subjectHDE ALERpt_PT
dc.titleMonitoring Adherence to Asthma Inhalers Using the InspirerMundi App: Analysis of Real-World, Medium-Term Feasibility Studiespt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.startPage649506pt_PT
oaire.citation.volume3pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Front Med Technol 2021_649506.pdf
Size:
1.49 MB
Format:
Adobe Portable Document Format
Download

Collections

ALER - Artigos